Search Results - Mohammed Alshalalfa

Refine Results
  1. 1
    Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures

    Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures by Mohammed Alshalalfa, Reda Alhajj

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

    Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma by Harrison Tsai, Jonathan Lehrer, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni, Tamara L. Lotan

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Racial Differences in Genomic Profiling of Prostate Cancer

    Racial Differences in Genomic Profiling of Prostate Cancer by Brandon A. Mahal, Mohammed Alshalalfa, Kevin H. Kensler, Ilkania M. Chowdhury-Paulino, Philip W. Kantoff, Lorelei A. Mucci, Edward M. Schaeffer, Daniel E. Spratt, Kosj Yamoah, Paul L. Nguyen, Timothy R. Rebbeck

    Published 2020
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  4. 4
    The lncRNAs <i>PCGEM1</i> and <i>PRNCR1</i> are not implicated in castration resistant prostate cancer

    The lncRNAs <i>PCGEM1</i> and <i>PRNCR1</i> are not implicated in castration resistant prostate cancer by John R. Prensner, Anirban Sahu, Matthew K. Iyer, Rohit Malik, Benjamin C. Chandler, Irfan A. Asangani, Anton Poliakov, Ismael A. Vergara, Mohammed Alshalalfa, Robert B. Jenkins, Elai Davicioni, Felix Y. Feng, Arul M. Chinnaiyan

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location

    Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location by Farzana A. Faisal, Debasish Sundi, Jeffrey J. Tosoian, Voleak Choeurng, Mohammed Alshalalfa, Ashley E. Ross, Eric A. Klein, Robert B. Den, Adam P. Dicker, Nicholas Erho, Elai Davicioni, Tamara L. Lotan, Edward M. Schaeffer

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer

    Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer by Anirban P. Mitra, Lucia L.C. Lam, Mercedeh Ghadessi, Nicholas Erho, Ismael A. Vergara, Mohammed Alshalalfa, Christine Buerki, Zaid Haddad, Thomas Sierocinski, Timothy J. Triche, Eila C. Skinner, Elai Davicioni, Siamak Daneshmand, Peter C. Black

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies

    Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies by Wolfgang Jäger, Hui Xue, Tetsutaro Hayashi, Claudia Janßen, Shannon Awrey, Alexander W. Wyatt, Shawn Anderson, Igor Moskalev, Anne Haegert, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni, Ladan Fazli, Estelle Li, Colin C. Collins, Yuzhuo Wang, Peter C. Black

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens

    Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens by Beatrice S. Knudsen, Hyung L. Kim, Nicholas Erho, Heesun Shin, Mohammed Alshalalfa, Lucia L.C. Lam, Imelda Tenggara, Karen Chadwich, Theodorus van der Kwast, Neil Fleshner, Elai Davicioni, Peter R. Carroll, Matthew R. Cooperberg, June M. Chan, Jeffry Simko

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort

    SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort by Michael H. Johnson, Ashley E. Ross, Mohammed Alshalalfa, Nicholas Erho, Kasra Yousefi, Stephanie Glavaris, Helen Fedor, Misop Han, Sheila F. Faraj, Stephania Martins Bezerra, George J. Netto, Alan W. Partin, Bruce J. Trock, Elai Davicioni, Edward M. Schaeffer

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome

    Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome by Sungyong You, Beatrice S. Knudsen, Nicholas Erho, Mohammed Alshalalfa, Mandeep Takhar, Hussam Al-Deen Ashab, Elai Davicioni, R. Jeffrey Karnes, Eric A. Klein, Robert B. Den, Ashley E. Ross, Edward M. Schaeffer, Isla P. Garraway, Jayoung Kim, Michael R. Freeman

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types

    Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types by William S. Chen, Mohammed Alshalalfa, Shuang G. Zhao, Yang Liu, Brandon A. Mahal, David A. Quigley, Ting Wei, Elai Davicioni, Timothy R. Rebbeck, Philip W. Kantoff, Christopher A. Maher, Karen E. Knudsen, Eric J. Small, Paul L. Nguyen, Felix Y. Feng

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer

    Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer by Nicole M. White, Shuang G. Zhao, Jin Zhang, Emily B. Rozycki, Ha X. Dang, Sandra D. McFadden, Abdallah M. Eteleeb, Mohammed Alshalalfa, Ismael A. Vergara, Nicholas Erho, Jeffrey M. Arbeit, R. Jeffrey Karnes, Robert B. Den, Elai Davicioni, Christopher A. Maher

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer

    The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer by Matthew R. Cooperberg, Nicholas Erho, June M. Chan, Felix Y. Feng, Nick Fishbane, Shuang G. Zhao, Jeffry Simko, Janet E. Cowan, Jonathan Lehrer, Mohammed Alshalalfa, Tyler Kolisnik, Jijumon Chelliserry, Jennifer Margrave, Maria Aranes, Marguerite du Plessis, Christine Buerki, Imelda Tenggara, Elai Davicioni, Peter R. Carroll

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas

    Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas by Harrison Tsai, Carlos L. Morais, Mohammed Alshalalfa, Hsueh‐Li Tan, Zaid Haddad, Jessica Hicks, Nilesh Gupta, Jonathan I. Epstein, George J. Netto, William B. Isaacs, Jun Luo, Rohit Mehra, Robert L. Vessella, R. Jeffrey Karnes, Edward M. Schaeffer, Elai Davicioni, Angelo M. De Marzo, Tamara L. Lotan

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies

    Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies by Radka Stoyanova, Alan Pollack, Mandeep Takhar, Charles M. Lynne, Nestor A. Parra, Lucia L.C. Lam, Mohammed Alshalalfa, Christine Buerki, Rosa Castillo, Mercè Jordà, Hussam Al-Deen Ashab, Oleksandr N. Kryvenko, Sanoj Punnen, Dipen J. Parekh, Matthew C. Abramowitz, Robert J. Gillies, Elai Davicioni, Nicholas Erho, Adrian Ishkanian

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer

    Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer by Deli Liu, Mandeep Takhar, Mohammed Alshalalfa, Nicholas Erho, Jonathan E. Shoag, Robert B. Jenkins, R. Jeffrey Karnes, Ashley E. Ross, Edward M. Schaeffer, Mark A. Rubin, Bruce J. Trock, Eric A. Klein, Robert B. Den, Scott A. Tomlins, Daniel E. Spratt, Elai Davicioni, Andrea Sboner, Christopher E. Barbieri

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes

    Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes by Scott A. Tomlins, Mohammed Alshalalfa, Elai Davicioni, Nicholas Erho, Kasra Yousefi, Shuang G. Zhao, Zaid Haddad, Robert B. Den, Adam P. Dicker, Bruce J. Trock, Angelo M. De Marzo, Ashley E. Ross, Edward M. Schaeffer, Eric A. Klein, Cristina Magi‐Galluzzi, R. Jeffrey Karnes, Robert B. Jenkins, Felix Y. Feng

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer

    Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer by Brandon A. Mahal, David D. Yang, Natalie Q. Wang, Mohammed Alshalalfa, Elai Davicioni, Voleak Choeurng, Edward M. Schaeffer, Ashley E. Ross, Daniel E. Spratt, Robert B. Den, Neil E. Martin, Kent W. Mouw, Peter F. Orio, Toni K. Choueiri, Mary-Ellen Taplin, Quoc‐Dien Trinh, Felix Y. Feng, Paul L. Nguyen

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

    The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair by Ayesha A. Shafi, Christopher McNair, Jennifer J. McCann, Mohammed Alshalalfa, Anton Shostak, Tesa Severson, Yanyun Zhu, Andries M. Bergman, Nicolas Gordon, Amy C. Mandigo, Saswati N. Chand, Peter Gallagher, Emanuela Dylgjeri, Talya S. Laufer, Irina A. Vasilevskaya, Matthew J. Schiewer, Michael Brunner, Felix Y. Feng, Wilbert Zwart, Karen E. Knudsen

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis

    Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis by Benjamin Benzon, Shuang G. Zhao, Michael C. Haffner, Mandeep Takhar, Nicholas Erho, Kasra Yousefi, Paula J. Hurley, Jennifer L. Bishop, Jeffrey J. Tosoian, Kamyar Ghabili, Mohammed Alshalalfa, Stephanie Glavaris, Brian W. Simons, Phuoc T. Tran, Elai Davicioni, R. Jeffrey Karnes, Karim Boudadi, Emmanuel S. Antonarakis, Edward M. Schaeffer, Charles G. Drake, Felix Y. Feng, Ashley E. Ross

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: